Clermont-Ferrand, France

Jean-Claude Teulade



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Jean-Claude Teulade

Introduction

Jean-Claude Teulade is an innovative inventor based in Clermont-Ferrand, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications against viral infections.

Latest Patents

Jean-Claude Teulade holds a patent for a series of novel imidazo[1,2-α]pyrrolo[3,2-c]pyridines, also known as 6H-1,3a,6-Tri-aza-αy-indacenes. This invention relates to the preparation and application of these compounds as medicines aimed at treating or preventing viral infections, especially those caused by viruses belonging to the Flaviviridae family. Notably, his research targets the Bovine Viral Diarrhea virus (BVDV), highlighting its potential impact on veterinary medicine.

Career Highlights

Throughout his career, Teulade has been associated with prestigious institutions, including Université d'Auvergne Clermont 1 and Université François Rabelais Tours. His work at these universities underscores his commitment to advancing pharmaceutical research and addressing critical health challenges.

Collaborations

Jean-Claude Teulade has collaborated with notable researchers in his field, including Johan Neyts and Jan Paeshuyse. These partnerships have enabled him to push the boundaries of medicinal research further and contribute to the scientific community more effectively.

Conclusion

Jean-Claude Teulade stands out as an accomplished inventor whose work has the potential to revolutionize treatments for viral infections. His patent and collaborative efforts in the academic realm reflect a dedicated pursuit of innovation that benefits both human and animal health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…